Search research articles
Contact Us
Filters
Showing results (31-40 of 141) with videos related to
Page
of 15
Sort By:
Clinical Genitourinary Cancer
|
May 19, 2021
A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma
Simon Chowdhury, Jeffery R Infante, Robert Hawkins, et al.
Cancer
|
April 23, 2013
Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older
Darren R Feldman, Martin H Voss, Erin P Jacobsen, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy
Michael Lattanzi, Fang-Ming Deng, Luis A Chiriboga, et al.
The Lancet. Oncology
|
November 13, 2018
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
Martin H Voss, Albert Reising, Yuan Cheng, et al.
Clinical Genitourinary Cancer
|
September 26, 2015
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
Chung-Han Lee, Andreas M Hötker, Martin H Voss, et al.
Clinical Genitourinary Cancer
|
February 13, 2021
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic
Michal Sarfaty, Darren R Feldman, Michael J Morris, et al.
The Oncologist
|
June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
Maria I Carlo, Ana M Molina, Yulia Lakhman, et al.
British Journal of Cancer
|
October 7, 2020
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
Chung-Han Lee, Robert J Motzer, Hilary Glen, et al.
Cancer
|
September 8, 2011
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
Ana M Molina, Darren R Feldman, Martin H Voss, et al.
Journal for Immunotherapy of Cancer
|
February 11, 2021
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
Jason Beattie, Hira Rizvi, Paige Fuentes, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 141) with videos related to
Sort By:
Page
of 15
Clinical Genitourinary Cancer
|
May 19, 2021
A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma
Simon Chowdhury, Jeffery R Infante, Robert Hawkins, et al.
Cancer
|
April 23, 2013
Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older
Darren R Feldman, Martin H Voss, Erin P Jacobsen, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy
Michael Lattanzi, Fang-Ming Deng, Luis A Chiriboga, et al.
The Lancet. Oncology
|
November 13, 2018
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
Martin H Voss, Albert Reising, Yuan Cheng, et al.
Clinical Genitourinary Cancer
|
September 26, 2015
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
Chung-Han Lee, Andreas M Hötker, Martin H Voss, et al.
Clinical Genitourinary Cancer
|
February 13, 2021
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic
Michal Sarfaty, Darren R Feldman, Michael J Morris, et al.
The Oncologist
|
June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
Maria I Carlo, Ana M Molina, Yulia Lakhman, et al.
British Journal of Cancer
|
October 7, 2020
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
Chung-Han Lee, Robert J Motzer, Hilary Glen, et al.
Cancer
|
September 8, 2011
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
Ana M Molina, Darren R Feldman, Martin H Voss, et al.
Journal for Immunotherapy of Cancer
|
February 11, 2021
Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
Jason Beattie, Hira Rizvi, Paige Fuentes, et al.
Page
of 15